Copyright Reports & Markets. All rights reserved.

Global Bone Morphogenetic Protein Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Bone Morphogenetic Protein Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Bone Morphogenetic Protein Market Size Growth Rate by Product
      • 1.4.2 rhBMP-2
      • 1.4.3 rhBMP-7
    • 1.5 Market by End User
      • 1.5.1 Global Bone Morphogenetic Protein Market Size Growth Rate by End User
      • 1.5.2 Spinal Fusion
      • 1.5.3 Trauma
      • 1.5.4 Reconstruction
      • 1.5.5 Oral Maxillofacial
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Bone Morphogenetic Protein Market Size
      • 2.1.1 Global Bone Morphogenetic Protein Revenue 2014-2025
      • 2.1.2 Global Bone Morphogenetic Protein Sales 2014-2025
    • 2.2 Bone Morphogenetic Protein Growth Rate by Regions
      • 2.2.1 Global Bone Morphogenetic Protein Sales by Regions
      • 2.2.2 Global Bone Morphogenetic Protein Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Bone Morphogenetic Protein Sales by Manufacturers
      • 3.1.1 Bone Morphogenetic Protein Sales by Manufacturers
      • 3.1.2 Bone Morphogenetic Protein Sales Market Share by Manufacturers
      • 3.1.3 Global Bone Morphogenetic Protein Market Concentration Ratio (CR5 and HHI)
    • 3.2 Bone Morphogenetic Protein Revenue by Manufacturers
      • 3.2.1 Bone Morphogenetic Protein Revenue by Manufacturers (2014-2019)
      • 3.2.2 Bone Morphogenetic Protein Revenue Share by Manufacturers (2014-2019)
    • 3.3 Bone Morphogenetic Protein Price by Manufacturers
    • 3.4 Bone Morphogenetic Protein Manufacturing Base Distribution, Product Types
      • 3.4.1 Bone Morphogenetic Protein Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Bone Morphogenetic Protein Product Type
      • 3.4.3 Date of International Manufacturers Enter into Bone Morphogenetic Protein Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Bone Morphogenetic Protein Sales by Product
    • 4.2 Global Bone Morphogenetic Protein Revenue by Product
    • 4.3 Bone Morphogenetic Protein Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Bone Morphogenetic Protein Breakdown Data by End User

    6 North America

    • 6.1 North America Bone Morphogenetic Protein by Countries
      • 6.1.1 North America Bone Morphogenetic Protein Sales by Countries
      • 6.1.2 North America Bone Morphogenetic Protein Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Bone Morphogenetic Protein by Product
    • 6.3 North America Bone Morphogenetic Protein by End User

    7 Europe

    • 7.1 Europe Bone Morphogenetic Protein by Countries
      • 7.1.1 Europe Bone Morphogenetic Protein Sales by Countries
      • 7.1.2 Europe Bone Morphogenetic Protein Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Bone Morphogenetic Protein by Product
    • 7.3 Europe Bone Morphogenetic Protein by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Bone Morphogenetic Protein by Countries
      • 8.1.1 Asia Pacific Bone Morphogenetic Protein Sales by Countries
      • 8.1.2 Asia Pacific Bone Morphogenetic Protein Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Bone Morphogenetic Protein by Product
    • 8.3 Asia Pacific Bone Morphogenetic Protein by End User

    9 Central & South America

    • 9.1 Central & South America Bone Morphogenetic Protein by Countries
      • 9.1.1 Central & South America Bone Morphogenetic Protein Sales by Countries
      • 9.1.2 Central & South America Bone Morphogenetic Protein Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Bone Morphogenetic Protein by Product
    • 9.3 Central & South America Bone Morphogenetic Protein by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Bone Morphogenetic Protein by Countries
      • 10.1.1 Middle East and Africa Bone Morphogenetic Protein Sales by Countries
      • 10.1.2 Middle East and Africa Bone Morphogenetic Protein Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Bone Morphogenetic Protein by Product
    • 10.3 Middle East and Africa Bone Morphogenetic Protein by End User

    11 Company Profiles

    • 11.1 Fidia
      • 11.1.1 Fidia Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Fidia Bone Morphogenetic Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Fidia Bone Morphogenetic Protein Products Offered
      • 11.1.5 Fidia Recent Development
    • 11.2 Medtronic
      • 11.2.1 Medtronic Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Medtronic Bone Morphogenetic Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Medtronic Bone Morphogenetic Protein Products Offered
      • 11.2.5 Medtronic Recent Development
    • 11.3 TRB Chemedica
      • 11.3.1 TRB Chemedica Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 TRB Chemedica Bone Morphogenetic Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 TRB Chemedica Bone Morphogenetic Protein Products Offered
      • 11.3.5 TRB Chemedica Recent Development
    • 11.4 Meda Pharma
      • 11.4.1 Meda Pharma Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Meda Pharma Bone Morphogenetic Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Meda Pharma Bone Morphogenetic Protein Products Offered
      • 11.4.5 Meda Pharma Recent Development
    • 11.5 Sanofi Genzyme
      • 11.5.1 Sanofi Genzyme Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Sanofi Genzyme Bone Morphogenetic Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Sanofi Genzyme Bone Morphogenetic Protein Products Offered
      • 11.5.5 Sanofi Genzyme Recent Development
    • 11.6 Depuy Synthes
      • 11.6.1 Depuy Synthes Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Depuy Synthes Bone Morphogenetic Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Depuy Synthes Bone Morphogenetic Protein Products Offered
      • 11.6.5 Depuy Synthes Recent Development
    • 11.7 Bioventus
      • 11.7.1 Bioventus Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Bioventus Bone Morphogenetic Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Bioventus Bone Morphogenetic Protein Products Offered
      • 11.7.5 Bioventus Recent Development
    • 11.8 Laboratoire Genevrier
      • 11.8.1 Laboratoire Genevrier Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Laboratoire Genevrier Bone Morphogenetic Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Laboratoire Genevrier Bone Morphogenetic Protein Products Offered
      • 11.8.5 Laboratoire Genevrier Recent Development
    • 11.9 Recordati
      • 11.9.1 Recordati Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Recordati Bone Morphogenetic Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Recordati Bone Morphogenetic Protein Products Offered
      • 11.9.5 Recordati Recent Development
    • 11.10 Stryker
      • 11.10.1 Stryker Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Stryker Bone Morphogenetic Protein Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Stryker Bone Morphogenetic Protein Products Offered
      • 11.10.5 Stryker Recent Development
    • 11.11 RTI Biologics
    • 11.12 Croma-Pharma
    • 11.13 Zimmer Biomet

    12 Future Forecast

    • 12.1 Bone Morphogenetic Protein Market Forecast by Regions
      • 12.1.1 Global Bone Morphogenetic Protein Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Bone Morphogenetic Protein Revenue Forecast by Regions 2019-2025
    • 12.2 Bone Morphogenetic Protein Market Forecast by Product
      • 12.2.1 Global Bone Morphogenetic Protein Sales Forecast by Product 2019-2025
      • 12.2.2 Global Bone Morphogenetic Protein Revenue Forecast by Product 2019-2025
    • 12.3 Bone Morphogenetic Protein Market Forecast by End User
    • 12.4 North America Bone Morphogenetic Protein Forecast
    • 12.5 Europe Bone Morphogenetic Protein Forecast
    • 12.6 Asia Pacific Bone Morphogenetic Protein Forecast
    • 12.7 Central & South America Bone Morphogenetic Protein Forecast
    • 12.8 Middle East and Africa Bone Morphogenetic Protein Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Bone Morphogenetic Protein Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Bone morphogenetic proteins (BMPs) are growth factors that induce the formation of bone after a fracture. In nature, these proteins have a critical role during embryonic development in the formation of the skeleton.
      The global Bone Morphogenetic Protein market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Bone Morphogenetic Protein market based on company, product type, end user and key regions.

      This report studies the global market size of Bone Morphogenetic Protein in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bone Morphogenetic Protein in these regions.
      This research report categorizes the global Bone Morphogenetic Protein market by top players/brands, region, type and end user. This report also studies the global Bone Morphogenetic Protein market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Fidia
      Medtronic
      TRB Chemedica
      Meda Pharma
      Sanofi Genzyme
      Depuy Synthes
      Bioventus
      Laboratoire Genevrier
      Recordati
      Stryker
      RTI Biologics
      Croma-Pharma
      Zimmer Biomet

      Market size by Product
      rhBMP-2
      rhBMP-7
      Market size by End User
      Spinal Fusion
      Trauma
      Reconstruction
      Oral Maxillofacial

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Bone Morphogenetic Protein market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Bone Morphogenetic Protein market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Bone Morphogenetic Protein companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Bone Morphogenetic Protein submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Bone Morphogenetic Protein are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bone Morphogenetic Protein market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now